ArcticZymes Technologies ASA is a holding company, which engages in the development, manufacture, and marketing of immunomodulatory products and cold adapted marine enzymes. It operates through the Enzymes and Beta-Glucans segments. The Enzymes segment consists of sales revenues and operating expenses associated with the subsidiary ArcticZymes AS, which develops and markets recombinant enzymes for use in life science research, molecular diagnostics, and bio-manufacturing. The Beta-Glucans segment refers to revenues and operating expenses of the subsidiary Biotec BetaGlucans AS, which develops active pharmaceutical ingredients produced in-house, in addition to a variety of ingredients, and end-user products. The company was founded by Jan Raa and Gunnar Rorstad in November 1990 and is headquartered in Tromso, Norway.